TGFB1 and temporomandibular joint disorder: Using TGF-β-releasing microspheres as implantable scaffolds for the formation of cell spheroids is beneficial for maintaining the biological activity of spheroids, and directing chondrocyte differentiation, thus providing a promising strategy for tissue engineering-based treatment of TMD.